Cell_NN
type_NN
specificity_NN
and_CC
activation_NN
requirements_NNS
for_IN
NFAT-1_NN
-LRB-_-LRB-
nuclear_JJ
factor_NN
of_IN
activated_VBN
T-cells_NN
-RRB-_-RRB-
transcriptional_JJ
activity_NN
determined_VBN
by_IN
a_DT
new_JJ
method_NN
using_VBG
transgenic_JJ
mice_NNS
to_TO
assay_NN
transcriptional_JJ
activity_NN
of_IN
an_DT
individual_JJ
nuclear_JJ
factor_NN
._.

Nuclear_JJ
factor_NN
of_IN
activated_VBN
T-cells_NNS
-LRB-_-LRB-
NFAT-1_NN
-RRB-_-RRB-
is_VBZ
a_DT
transcription_NN
factor_NN
which_WDT
is_VBZ
considered_VBN
to_TO
be_VB
an_DT
important_JJ
regulator_NN
in_IN
early_JJ
T-cell_NN
activation_NN
._.

We_PRP
have_VBP
developed_VBN
a_DT
system_NN
to_TO
monitor_VB
the_DT
transcriptional_JJ
activity_NN
of_IN
NFAT-1_NN
at_IN
the_DT
single_JJ
cell_NN
level_NN
in_IN
whole_JJ
animals_NNS
._.

The_DT
system_NN
is_VBZ
based_VBN
on_IN
the_DT
use_NN
of_IN
an_DT
oligomerized_JJ
NFAT-1_NN
binding_NN
motif_NN
that_WDT
directs_VBZ
transcription_NN
of_IN
SV40_NN
T-antigen_NN
in_IN
transgenic_JJ
mice_NNS
._.

This_DT
report_NN
represents_VBZ
the_DT
first_JJ
demonstration_NN
that_IN
a_DT
multimerized_JJ
short_JJ
binding_NN
motif_NN
can_MD
function_VB
appropriately_RB
in_IN
transgenic_JJ
mice_NNS
._.

NFAT-1_NN
activity_NN
had_VBD
previously_RB
been_VBN
thought_VBN
to_TO
be_VB
confined_VBN
to_TO
activated_VBN
T-lymphocytes_NNS
upon_IN
release_NN
of_IN
intracellular_JJ
calcium_NN
._.

By_IN
targeting_VBG
NFAT-1-dependent_JJ
gene_NN
expression_NN
in_IN
transgenic_JJ
mice_NNS
we_PRP
discovered_VBD
new_JJ
sites_NNS
of_IN
NFAT-1_NN
activity_NN
._.

Besides_IN
in_IN
T-lymphocytes_NNS
NFAT-1_NN
activity_NN
could_MD
also_RB
be_VB
induced_VBN
in_IN
T-lymphocyte-depleted_JJ
spleen_NN
cells_NNS
and_CC
purified_VBN
B-lymphocytes_NNS
and_CC
requires_VBZ
agents_NNS
that_WDT
both_CC
release_VBP
intracellular_JJ
calcium_NN
and_CC
activate_VBP
protein_NN
kinase_NN
C_NN
._.

A_DT
difference_NN
in_IN
the_DT
time_NN
course_NN
of_IN
appearance_NN
of_IN
NFAT-1_NN
activity_NN
between_IN
T-lymphocytes_NNS
and_CC
non-T-lymphocytes_NNS
was_VBD
revealed_VBN
._.

Constitutive_JJ
expression_NN
was_VBD
observed_VBN
in_IN
a_DT
small_JJ
population_NN
of_IN
cells_NNS
in_IN
the_DT
dermis_NN
and_CC
some_DT
mice_NNS
have_VBP
developed_VBN
skin_NN
lesions_NNS
._.

Interestingly_RB
,_,
the_DT
tissue_NN
pattern_NN
of_IN
expression_NN
of_IN
the_DT
NFAT-1_NN
activity_NN
resembles_VBZ
the_DT
expression_NN
pattern_NN
described_VBN
for_IN
HIV-LTR\/tat_NN
transgenic_JJ
mice_NNS
-LRB-_-LRB-
Vogel_NNP
,_,
J._NNP
,_,
Hinrichs_NNP
,_,
S._NNP
H._NNP
,_,
Reynolds_NNP
,_,
R._NNP
K._NNP
,_,
Luciw_NNP
,_,
P._NNP
A._NNP
,_,
and_CC
Jay_NNP
,_,
G._NNP
-LRB-_-LRB-
1988_CD
-RRB-_-RRB-
Nature_NNP
335_CD
,_,
606-611_CD
-RRB-_-RRB-
._.

This_DT
similarity_NN
in_IN
expression_NN
and_CC
the_DT
fact_NN
that_IN
NFAT-1_NN
has_VBZ
been_VBN
shown_VBN
to_TO
bind_VB
functional_JJ
sequences_NNS
in_IN
HIV-LTR_NN
suggest_VBP
a_DT
role_NN
for_IN
NFAT-1_NN
in_IN
dermal_JJ
activation_NN
of_IN
the_DT
HIV-LTR_NN
._.

